An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease

INTRODUCTION: Real-world treatment persistence to ustekinumab for Crohn’s disease (CD) was studied using Australian Pharmaceutical Benefits Scheme (PBS) data. Demographic and treatment pattern characteristics were also investigated. METHODS: Our retrospective cohort analysis included PBS 10% sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Tzu Hsiang, Puig, Andrea, Khuong, Thang, Kouhkamari, Mahsa H, Che, Samuel, Huang, Tom Hsun-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215905/
https://www.ncbi.nlm.nih.gov/pubmed/34163137
http://dx.doi.org/10.2147/BTT.S310076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215905/
https://www.ncbi.nlm.nih.gov/pubmed/34163137
http://dx.doi.org/10.2147/BTT.S310076

Ejemplares similares